Macrocyclic Peptides that Selectively Inhibit the Mycobacterium tuberculosis Proteasome-Reference-Cited by-同舟云学术

Macrocyclic Peptides that Selectively Inhibit the Mycobacterium tuberculosis Proteasome

Published:2021-05-05 Issue:9 Volume:64 Page:6262-6272
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zhang Hao¹^ORCID,Hsu Hao-Chi²,Kahne Shoshanna C.³,Hara Ryoma⁴,Zhan Wenhu¹^ORCID,Jiang Xiuju¹,Burns-Huang Kristin¹,Ouellette Tierra¹,Imaeda Toshihiro⁴,Okamoto Rei⁴,Kawasaki Masanori⁴,Michino Mayako⁴,Wong Tzu-Tshin⁴,Toita Akinori⁴,Yukawa Takafumi⁴,Moraca Francesca⁵^ORCID,Vendome Jeremie⁵,Saha Priya¹,Sato Kenjiro⁴,Aso Kazuyoshi⁴,Ginn John⁴,Meinke Peter T.⁴,Foley Michael⁴,Nathan Carl F.¹,Darwin K. Heran³,Li Huilin²^ORCID,Lin Gang¹^ORCID

Affiliation:

1. Department of Microbiology & Immunology, Weill Cornell Medicine, 1300 York Avenue, New York, New York 10065, United States

2. Department of Structural Biology, Van Andel Institute, 333 Bostwick Avenue NE, Grand Rapids, Michigan 49503, United States

3. Department of Microbiology, New York University School of Medicine, 430 E. 29th Street, New York, New York 10016, United States

4. Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th Street, New York, New York 10065, United States

5. Schrödinger, Inc., New York, New York 10036, United States

Funder

Takeda Pharmaceutical Company

National Institute of Allergy and Infectious Diseases

Michigan Economic Development Corporation

National Institutes of Health

Milstein Program in Translational Medicine